UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000455
Receipt number R000000553
Scientific Title A randomized controlled trial on therapeutic effects of sub-Tenon's capsule injection of triamcinolone acetonide in prevention of occurrence and inhibition of progression of diabetic macular edema caused by panretinal photocoagulation
Date of disclosure of the study information 2006/07/27
Last modified on 2009/01/27 15:21:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial on therapeutic effects of sub-Tenon's capsule injection of triamcinolone acetonide in prevention of occurrence and inhibition of progression of diabetic macular edema caused by panretinal photocoagulation

Acronym

A randomized controlled trial on therapeutic effects of sub-Tenon's capsule injection of triamcinolone acetonide in prevention of occurrence and inhibition of progression of diabetic macular edema caused by panretinal photocoagulation

Scientific Title

A randomized controlled trial on therapeutic effects of sub-Tenon's capsule injection of triamcinolone acetonide in prevention of occurrence and inhibition of progression of diabetic macular edema caused by panretinal photocoagulation

Scientific Title:Acronym

A randomized controlled trial on therapeutic effects of sub-Tenon's capsule injection of triamcinolone acetonide in prevention of occurrence and inhibition of progression of diabetic macular edema caused by panretinal photocoagulation

Region

Japan


Condition

Condition

diabetic retinopathy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this trial is to evaluate the safety and efficacy of sub-Tenon's capsule injection of triamcinolone acetonide in the prevention of occurrence and the inhibition of progression of diabetic macular edema caused by panretinal photocoagulation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Best-corrected visual acuity (logarithm of the minimum angle of resolution) at 6 months after treatment

Key secondary outcomes

Best-corrected visual acuity (logMAR) at 1,3 months after treatment
Foveal thickness at 1week, 1,3,6 months after treatment
Intraocular pressure at 1,3,6 months after treatment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A single sub-Tenon's injection of triamcinolone acetonide (20mg) and panretinal photocoagulation

Interventions/Control_2

Panretinal photocoagulation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy, whose retinopathy is bilateral and symmetrical, and panretinal ptotocoagulation is required for.

Key exclusion criteria

(1)Intraocular pressure is more than 21 mmHg
(2)Massive cataract
(3)Ocular pathology other than diabetic retinopathy (e.g., glaucoma, age-related macular degeneration)
(4)Tractional retinal detachment or massive proliferation
(5)Vitreous hemorrhage
(6)Unilateral or asymmetrical diabetic retinopathy
(7)Neovascular glaucoma
(8)Previous vitreoretinal surgery
(9)Previous panretinal photocoagulation
(10)Pregnant or lactating women

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mihori Kita

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code


Address

54 Shogoinkawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-751-3250

Email



Public contact

Name of contact person

1st name
Middle name
Last name Noriyuki Unoki

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code


Address

54 Shogoinkawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-751-3250

Homepage URL


Email

noriharu@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Graduate School of Medicine, Department of Ophthalmology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 07 Month 20 Day

Date of IRB


Anticipated trial start date

2006 Year 07 Month 01 Day

Last follow-up date

2007 Year 10 Month 01 Day

Date of closure to data entry

2007 Year 11 Month 01 Day

Date trial data considered complete

2007 Year 12 Month 01 Day

Date analysis concluded

2008 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 07 Month 27 Day

Last modified on

2009 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000553


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name